A share price of Astrazeneca plc ADR [AZN] is currently trading at $78.67, up 0.98%. An important factor to consider is whether the stock is rising or falling in short-term value. The AZN shares have gain 2.34% over the last week, with a monthly amount drifted -10.21%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on September 13, 2024, when Deutsche Bank downgraded its rating to a Sell. Previously, Goldman started tracking the stock with Buy rating on May 30, 2024, and set its price target to $97. On April 16, 2024, upgrade upgraded it’s rating to Hold. Deutsche Bank downgraded its rating to a Sell. Morgan Stanley initiated its recommendation with a Overweight and recommended $85 as its price target on January 23, 2024. In a note dated January 03, 2024, Jefferies downgraded an Hold rating on this stock and revised its target price from $78.50 to $70.
Astrazeneca plc ADR experienced fluctuations in its stock price throughout the past year between $60.47 and $87.68. Currently, Wall Street analysts expect the stock to reach $84.33 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $78.67 at the most recent close of the market. An investor can expect a potential return of 7.19% based on the average AZN price forecast.
Analyzing the AZN fundamentals
Trailing Twelve Months sales for Astrazeneca plc ADR [NASDAQ:AZN] were 49.13B which represents 13.33% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.19%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.17 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.82.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.00 points at the first support level, and at 77.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.07, and for the 2nd resistance point, it is at 79.47.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Astrazeneca plc ADR [NASDAQ:AZN] is 0.89. On the other hand, the Quick Ratio is 0.69, and the Cash Ratio is 0.24. Considering the valuation of this stock, the price to sales ratio is 4.96, the price to book ratio is 6.17 and price to earnings (TTM) ratio is 38.12.
